Distinguished Scientist
Johnson & Johnson Innovative Medicine
Beverly Knight, Ph.D., is currently a Distinguished Scientist in DMPK at Johnson & Johnson Innovative Medicine. Prior to joining J&J, Bev received a bachelor’s degree in chemistry, followed by a doctoral degree in Pharmacokinetics from the University of North Carolina at Chapel Hill. Her training and expertise focus on the intestine and drug absorption processes.
She began her post-graduate career at Takeda, gaining drug discovery experience across several therapeutic areas over 6 years. This was followed by 5 years at Pfizer, working in Clinical Pharmacology, supporting both large and small molecule programs, including involvement in several biosimilar teams. She gained a lot of regulatory experience, including supporting the submission, advisory committee meeting, and reapproval of the ADC Mylotarg.
Bev joined Janssen in 2018 as a Development DMPK lead. She had the opportunity to co-lead a Discovery team for a program with unique absorption-related issues. The program progressed in record time and is now completing Phase 3 studies.
As a Therapeutic Area Lead (TAL) for Immunology within DMPK, she has oversight across the J&J Immunology Discovery and Development portfolio and the DMPK project leads supporting these programs.